Skip to main content

Advertisement

Log in

Histamine release-neutralization assay for sera of patients with atopic dermatitis and/or cholinergic urticaria is useful to screen type I hypersensitivity against sweat antigens

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

We previously reported that about 80 % of patients with atopic dermatitis and 60 % with cholinergic urticaria revealed type I allergy against sweat, by means of skin test against autologous sweat and/or histamine-release test for peripheral blood basophils with semi-purified sweat antigen. In this study, we developed an assay for sera to neutralize histamine-releasing activity of semi-purified sweat antigen. The semi-purified sweat antigen was pre-incubated with serially diluted sera for 30 min at 37 °C and was subjected to histamine-release activity. Histamine release-neutralization (HRN) activities were calculated by measuring the amount of histamine release from basophils in the presence or absence of semi-purified sweat antigen. Of 62 subjects, 39 showed positive histamine release (≥5 %) from their basophils in response to semi-purified sweat antigen, and sera of 34 out of 39 subjects (87.2 %) were also positive in HRN activity (≥10 %). The specificity of the HRN assay was 0.522. Moreover, HRN activities in sera were largely correlated with degrees of histamine release from peripheral blood basophils of the same donors in response to sweat antigen. To identify the substance that neutralizes histamine-release activity, we removed IgE and IgG from the sera of HRN (+) subjects by column chromatography. The HRN activities in 30 out of 42 sera were largely reduced by the removal of IgG. On the other hand, sera of four subjects lost HRN activity by the removal of IgE, suggesting that the majority of HRN (+) subjects have serum IgG against the sweat antigen as well as IgE bound to peripheral basophils. Thus, the HRN assay maybe useful for the screening of type I allergy against sweat antigen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

HRA:

Histamine-release assay

HRN:

Histamine release-neutralization

IgE:

Immunoglobulin E

IgG:

Immunoglobulin G

CAP-FEIA:

Capsulated-fluorenzymeimmunoassay

ELISA:

Enzyme-linked immunosorbent assay

ANOVA:

Analysis of variance

FACS:

Fluorescence activated cell sorter

ROC:

Receiver-operator characteristic

References

  1. Aalberse R (2011) The role of IgG antibodies in allergy and immunotherapy. Allergy 66(Suppl 95):28–30

    Article  PubMed  Google Scholar 

  2. Boguniewicz M, Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242:233–246

    Article  PubMed  CAS  Google Scholar 

  3. Buddenkotte J, Steinhoff M (2010) Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy 65:805–821

    Article  PubMed  CAS  Google Scholar 

  4. Celik-Bilgili S, Mehl A, Verstege A, Staden U, Nocon M, Beyer K, Niggemann B (2005) The predictive value of specific immunoglobulin E levels in serum for the outcome of oral food challenges. Clin Exp Allergy 35:268–273

    Article  PubMed  CAS  Google Scholar 

  5. Codreanu F, Morisset M, Cordebar V, Kanny G, Moneret-Vautrin DA (2006) Risk of allergy to food proteins in topical medicinal agents and cosmetics. Eur Ann Allergy Clin Immunol 38:126–130

    PubMed  CAS  Google Scholar 

  6. Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M, Calza AM, Giusti F, Lübbe J, Seidenari S, Ring J, European Task Force on Atopic Dermatitis/EADV Eczema Task Force (2009) ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 24:317–328

    Article  PubMed  Google Scholar 

  7. Griese M, Kusenbach G, Reinhardt D (1990) Histamine release test in comparison to standard tests in diagnosis of childhood allergic asthma. Ann Allergy 65:46–51

    PubMed  CAS  Google Scholar 

  8. Hanifin JM (1984) Atopic dermatitis. J Allergy Clin Immunol 73:211–226

    Article  PubMed  CAS  Google Scholar 

  9. Hide M, Tanaka T, Yamamura Y, Koro O, Yamamoto S (2002) IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis. Acta Derm Venereol 82:335–340

    Article  PubMed  CAS  Google Scholar 

  10. Kameyoshi Y, Tanaka T, Mochizuki M, Koro O, Mihara S, Hiragun T, Tanaka M, Hide M (2008) Taking showers at school is beneficial for children with severer atopic dermatitis. Arerugi 57:130–137 (in Japanese)

    PubMed  Google Scholar 

  11. Koro O, Furutani K, Hide M, Yamada S, Yamamoto S (1999) Chemical mediators in atopic dermatitis: involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 103:663–670

    Article  PubMed  CAS  Google Scholar 

  12. Küster H, von Manstein S, Ruocchio-Wiglinghaus S, von Brunn A, Reinhardt D (2005) Mutations in the high-affinity IgE receptor beta-chain are not associated with nonresponder status. Allergy 60:1040–1045

    Article  PubMed  Google Scholar 

  13. Magerl M, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, Metz M, Młynek A, Maurer M, EAACI/GA2LEN/EDF/UNEV(2009) The definition and diagnostic testing of physical and cholinergic urticarias—EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy 64:1715–1721

    Google Scholar 

  14. Mochizuki H, Muramatsu R, Tadaki H, Mizuno T, Arakawa H, Morikawa A (2009) Effects of skin care with shower therapy on children with atopic dermatitis in elementary schools. Pediatr Dermatol 26:223–225

    Article  PubMed  Google Scholar 

  15. Murota H, Takahashi A, Nishioka M, Matsui S, Terao M, Kitaba S, Katayama I (2010) Showering reduces atopic dermatitis in elementary school students. Eur J Dermatol 20:410–411

    PubMed  Google Scholar 

  16. Plebani M (2003) Clinical value and measurement of IgE. Clin Biochem 36:453–469

    Article  PubMed  CAS  Google Scholar 

  17. Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, Sasaki R, Suto H, Takehara K, Committee for guidelines for the management of atopic dermatitis of Japanese dermatological association (2009) Guidelines for management of atopic dermatitis. J Dermatol 36:563–577

    Article  PubMed  Google Scholar 

  18. Sturm EM, Kranzelbinder B, Heinemann A, Groselj-Strele A, Aberer W, Sturm GJ (2010) CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation. Cytometry B Clin Cytom 78:308–318

    PubMed  Google Scholar 

  19. Takahagi S, Tanaka T, Ishii K, Suzuki H, Kameyoshi Y, Shindo H, Hide M (2009) Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 160:426–428

    Article  PubMed  CAS  Google Scholar 

  20. Tanaka A, Tanaka T, Suzuki H, Ishii K, Kameyoshi Y, Hide M (2006) Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis. Exp Dermatol 15:283–290

    Article  PubMed  CAS  Google Scholar 

  21. Zuberbier T (1998) Cholinergic urticaria. In: Henz BM, Zuberbier T, Grabbe J, Monroe E (eds) Urticaria. Springer, Berlin, pp 91–96

    Chapter  Google Scholar 

Download references

Acknowledgments

We thank Ms Kazue Uchida for the expert technical assistances, and Dr Faiz Kermani for his manuscript review. This work was supported in part by Health Science Research Grants from Ministry of Health, Welfare and Labor, Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michihiro Hide.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shindo, H., Ishii, K., Yanase, Y. et al. Histamine release-neutralization assay for sera of patients with atopic dermatitis and/or cholinergic urticaria is useful to screen type I hypersensitivity against sweat antigens. Arch Dermatol Res 304, 647–654 (2012). https://doi.org/10.1007/s00403-012-1236-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-012-1236-2

Keywords

Navigation